Active Specific Immunotherapy of Malignant Melanoma and Peptide Mimics of the Human High-Molecular-Weight Melanoma-Associated Antigen

作者: S. Ferrone , X. Wang

DOI: 10.1007/978-3-642-59537-0_23

关键词: Cellular immunityPhage displayMelanomaCancer researchAntigenMonoclonal antibodyAcral lentiginous melanomaImmunotherapyImmunityBiology

摘要: The realization that tumor cells utilize multiple mechanisms to escape from immune recognition and destruction has stimulated interest in developing applying immunotherapeutic strategies which target both humoral cellular immunity malignant cells. As a result, the tumor-associated antigens (TAA) used as targets have be expressed on cell surface membrane of Furthermore, since most TAA for active specific immunotherapy are self-antigens, challenge facing immunologists is develop effective breaking tolerance self-antigens. This chapter describes one strategy relies use peptide mimics human high-molecular-weight melanoma-associated antigen (HMW-MAA) immunogens implement patients with melanoma. These mimics, isolated phage display libraries by panning anti-HMW-MAA monoclonal antibodies, expected induce immunity.

参考文章(27)
Ralph A. Reisfeld, David A. Cheresh, Human tumor antigens. Advances in Immunology. ,vol. 40, pp. 323- 377 ,(1987) , 10.1016/S0065-2776(08)60242-4
Soldano Ferrone, Jean-Claude Bystryn, Philip Livingston, Specific Immunotherapy of Cancer With Vaccines ,(1993)
R O Schlingemann, F J Rietveld, S Ferrone, D J Ruiter, R M de Waal, Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds. American Journal of Pathology. ,vol. 136, pp. 1393- 1405 ,(1990)
Francesco M. Marincola, Elizabeth M. Jaffee, Daniel J. Hicklin, Soldano Ferrone, Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Advances in Immunology. ,vol. 74, pp. 181- 273 ,(2000) , 10.1016/S0065-2776(08)60911-6
P O Livingston, G Y Wong, S Adluri, Y Tao, M Padavan, R Parente, C Hanlon, M J Calves, F Helling, G Ritter, Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside. Journal of Clinical Oncology. ,vol. 12, pp. 1036- 1044 ,(1994) , 10.1200/JCO.1994.12.5.1036
JEAN-CLAUDE BYSTRYN, Immunogenicity and clinical activity of a polyvalent melanoma antigen vaccine prepared from shed antigens. Annals of the New York Academy of Sciences. ,vol. 690, pp. 190- 203 ,(1993) , 10.1111/J.1749-6632.1993.TB44008.X
L.L.C. Bonnycastle, J.S. Mehroke, M. Rashed, X. Gong, J.K. Scott, Probing the basis of antibody reactivity with a panel of constrained peptide libraries displayed by filamentous phage. Journal of Molecular Biology. ,vol. 258, pp. 747- 762 ,(1996) , 10.1006/JMBI.1996.0284